Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | SCD | O00767 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.31 |
| ▸ | PPARG | P37231 | 7/20 | 0.31 |
| ▸ | PPARD | Q03181 | 7/20 | 0.31 |
| ▸ | PPARA | Q07869 | 7/20 | 0.31 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.31 |
| ▸ | TSHR | P16473 | 4/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TLR2 | O60603 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | FABP4 | P15090 | 2/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4601184 | 0.98 | SCD (0.34) | PLA2G2ASCDGPR84PPARGPPARD | |
| SCHEMBL9367814 | 0.91 | DNM2 (0.34) | KMT2A | |
| SCHEMBL13415271 | 0.90 | DNM2 (0.36) | KMT2A | |
| SCHEMBL3133092 | 0.90 | DNM2 (0.36) | KMT2A | |
| SCHEMBL13415272 | 0.90 | DNM2 (0.36) | KMT2A | |
| SCHEMBL9089900 | 0.89 | — | — | |
| SCHEMBL3145900 | 0.87 | DNM2 (0.36) | KMT2A | |
| SCHEMBL13415269 | 0.87 | DNM2 (0.36) | KMT2A | |
| SCHEMBL3136072 | 0.87 | SLC29A1 (0.33) | MERTK | |
| SCHEMBL9091672 | 0.85 | SLC29A1 (0.35) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080251758-A1 | Triazine Compounds Comprising Substituents Containing Amino Groups and Carboxyl Groups | EVONIK DEGUSSA GMBH (DE) | 2008-10-16 | — | — | US | disclosed |
| EP-1948640-A2 | TRIAZINE COMPOUNDS COMPRISING SUBSTITUENTS CONTAINING AMINO GROUPS AND CARBOXYL GROUPS | Evonik Degussa GmbH (DE) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007057265-A2 | TRIAZINE COMPOUNDS COMPRISING SUBSTITUENTS CONTAINING AMINO GROUPS AND CARBOXYL GROUPS | EVONIK DEGUSSA GMBH (DE) | 2007-05-24 | — | — | WO | disclosed |
| EP-1787989-A1 | Triazine derivatives containing amino and carboxylic acic group | Degussa GmbH (DE) | 2007-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080251758-A1 | Triazine Compounds Comprising Substituents Containing Amino Groups and Carboxyl Groups | GTF3C5, BAZ2A, AADAC | PLA2G2A 4415/4885SCD 4126/4885GPR84 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.